Big Gain For Palisade Bio Inc.

Fri, Dec 30, 2022 at 07:06 PM

Palisade Bio Inc. (PALI:NASDAQ) jumped higher at $5.2, representing a gain of 61.5%. On Fri, Dec 30, 2022, PALI:NASDAQ touched a New 2-Week High of $5.2. The stock got featured on our News Catalysts scanner on Fri, Dec 30, 2022 at 08:55 AM in the 'PRIVATE PLACEMENT' category. From Fri, Dec 16, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days

The stock spiked on Fri, Dec 30, 2022 at $8.54 with a volume of 90M+.

About Palisade Bio Inc. (PALI:NASDAQ)

Palisade Bio Inc is a late-stage biopharma company.

Top 10 Gainers:

Dermata Therapeutics Inc. (DRMA:NASDAQ), 104.5%
180 Life Sciences Corp. (ATNF:NASDAQ), 79.37%
SoundHound AI Inc. (SOUN:NASDAQ), 71.84%
Palisade Bio Inc. (PALI:NASDAQ), 61.49%
F-star Therapeutics Inc. (FSTX:NASDAQ), 54.52%
Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 53.58%
United Insurance Holdings Corp. (UIHC:NASDAQ), 47.22%
EZGO Technologies Ltd. (EZGO:NASDAQ), 43.38%
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 40.29%
Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 39.26%